Volume 79, Issue 5, Pages (March 2011)

Slides:



Advertisements
Similar presentations
Volume 55, Issue 4, Pages (April 1999)
Advertisements

Selenium-deficient diet induces renal oxidative stress and injury via TGF-β1 in normal and diabetic rats  Alluru S. Reddi, Jaya S. Bollineni  Kidney International 
Tiffany Shao, Jordan Weinstein, Serge Jothy, Marc Goldstein 
Ellagic acid prevents monocrotaline-induced pulmonary artery hypertension via inhibiting NLRP3 inflammasome activation in rats  Bing Tang, Guang-xian.
Arterioscler Thromb Vasc Biol
Volume 79, Issue 11, Pages (June 2011)
Involvement of mtDNA Damage Elicited by Oxidative Stress in the Arsenical Skin Cancers  Chih-Hung Lee, Shi-Bei Wu, Chien-Hui Hong, Gwo-Shin Chen, Yau-Huei.
Volume 85, Issue 2, Pages (January 2014)
Endogenous superoxide dismutase activation by oral administration of riboflavin reduces abdominal aortic aneurysm formation in rats  Zhenhai Yu, MD, Keisuke.
Volume 78, Issue 11, Pages (December 2010)
Volume 85, Issue 3, Pages (March 2014)
Effects of suppressing intrarenal angiotensinogen on renal transforming growth factor- β1 expression in acute ureteral obstruction  Gyu-Tae Shin, Wook-Hwan.
Reactive oxygen species amplify protein kinase C signaling in high glucose-induced fibronectin expression by human peritoneal mesothelial cells  Hi Bahl.
Volume 67, Issue 1, Pages (January 2005)
Volume 76, Issue 1, Pages (July 2009)
Volume 76, Issue 11, Pages (December 2009)
Volume 69, Issue 9, Pages (May 2006)
Volume 59, Issue 4, Pages (April 2001)
Inhibition of cytochrome P450 2E1 and activation of transcription factor Nrf2 are renoprotective in myoglobinuric acute kidney injury  Zhe Wang, Sudhir.
Renal denervation prevents long-term sequelae of ischemic renal injury
The Case ∣ Acute renal failure and anemia
Volume 85, Issue 2, Pages (January 2014)
Volume 79, Issue 11, Pages (June 2011)
Volume 59, Issue 4, Pages (April 2001)
C.B. Marshall, J.W. Pippin, R.D. Krofft, S.J. Shankland 
Critical role for osteopontin in diabetic nephropathy
Volume 65, Issue 2, Pages (February 2004)
Volume 66, Issue 3, Pages (September 2004)
Volume 78, Issue 9, Pages (November 2010)
Volume 75, Issue 3, Pages (February 2009)
Volume 62, Issue 1, Pages (July 2002)
Genistein protects the kidney from cisplatin-induced injury
Mast cells decrease renal fibrosis in unilateral ureteral obstruction
Volume 87, Issue 2, Pages (February 2015)
Volume 73, Issue 5, Pages (March 2008)
Volume 67, Issue 4, Pages (April 2005)
Vitamin E attenuates crystal formation in rat kidneys: Roles of renal tubular cell death and crystallization inhibitors  H.-S. Huang, J. Chen, C.-F. Chen,
Volume 82, Issue 12, Pages (December 2012)
Volume 79, Issue 5, Pages (March 2011)
Volume 66, Issue 5, Pages (November 2004)
Volume 59, Issue 5, Pages (May 2001)
Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone-forming rats  David A. Bushinsky, Marc D. Grynpas, John.
Karl A. Nath, Anthony J. Croatt, Jill J. Haggard, Joseph P. Grande 
Volume 79, Issue 1, Pages (January 2011)
Role of meprin A in renal tubular epithelial cell injury
PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
Volume 87, Issue 2, Pages (February 2015)
Volume 74, Issue 7, Pages (October 2008)
Volume 63, Issue 2, Pages (February 2003)
Volume 72, Issue 8, Pages (October 2007)
Volume 54, Issue 5, Pages (November 1998)
Volume 87, Issue 2, Pages (February 2015)
Volume 66, Issue 2, Pages (August 2004)
Volume 70, Issue 10, Pages (November 2006)
Volume 55, Issue 4, Pages (April 1999)
Volume 85, Issue 1, Pages (January 2014)
Volume 73, Issue 11, Pages (June 2008)
Effect of bolus and divided feeding on urine ions and supersaturation in genetic hypercalciuric stone-forming rats  D.A. Bushinsky, A.C. Michalenka, K.L.
The pathological role of Bax in cisplatin nephrotoxicity
Volume 70, Issue 10, Pages (November 2006)
Volume 65, Issue 6, Pages (June 2004)
Volume 74, Issue 1, Pages (July 2008)
Hideyuki Murakami, Katsutoshi Yayama, Lee Chao, Julie Chao 
Volume 78, Issue 11, Pages (December 2010)
Parathyroid growth and regression in experimental uremia
Volume 63, Issue 1, Pages (January 2003)
Volume 56, Issue 6, Pages (December 1999)
The Case ∣ Hypokalemia associated with nephrocalcinosis
Jens Gaedeke, Nancy A. Noble, Wayne A. Border  Kidney International 
Volume 72, Issue 11, Pages (December 2007)
Presentation transcript:

Volume 79, Issue 5, Pages 538-545 (March 2011) 1,2,3,4,6-Penta-O-galloyl-beta-D-glucose reduces renal crystallization and oxidative stress in a hyperoxaluric rat model  Hyo-Jung Lee, Soo-Jin Jeong, Hyo-Jeong Lee, Eun-Ok Lee, Hyunsu Bae, John C. Lieske, Sung-Hoon Kim  Kidney International  Volume 79, Issue 5, Pages 538-545 (March 2011) DOI: 10.1038/ki.2010.458 Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 1 Effect of 1,2,3,4,6-penta-O-galloyl-β-D-glucose (PGG) on calcium oxalate (CaOx) crystal deposition in ethylene glycol (EG)-treated rat urine and kidneys. (a) Twenty-four hour rat urine samples on days 7, 14, and 21 were collected on ice in a metabolic cage and CaOx crystals with tetragonal bipyramidal habit were counted in a hemocytometer at × 400 magnification. Graph represents the average number of urinary CaOx crystals in the rat urine per high power field. (b) Histological specimens of rat kidney tissues (n=6/group) obtained on days 7, 14, and 21 following EG treatment were stained with hematoxylin and eosin (H&E), and the number of crystal depositions was counted. Graph represents the average number of crystal deposits in the kidney per high power field. Data represent means±s.d. *P<0.05, **P<0.01, and ***P<0.001 versus untreated control; ###P<0.001 versus EG; and !!!P<0.001 versus EG+P4 two-way analysis of variance followed by a post hoc analysis. C, untreated control (distilled water); EG, EG-treated group (0.8% EG/1% ammonium chloride (AC) (NH4Cl) in drinking water); and EG+P4 and EG+P20, two EG- and PGG-treated groups (0.8% EG/1% AC+4 or 20 mg/kg of PGG in 2% methylcellulose). Kidney International 2011 79, 538-545DOI: (10.1038/ki.2010.458) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 2 Effect of 1,2,3,4,6-penta-O-galloyl-β-D-glucose (PGG) on ROS production in human renal cells (HRCs) exposed to calcium oxalate (1 mM) and on the serum malondialdehyde (MDA) level in ethylene glycol (EG)-treated rats. (a) The levels of ROS in HRCs were measured using ROS-sensitive fluorometric probe, 2,7-dichlorofluorescein by flow cytometric analysis. Data are expressed as % cells positive. Data represent means±s.d. #P<0.05 versus untreated control and **P<0.01 versus oxalate. (b) The level of serum MDA was determined on days 7, 14, and 21 following EG treatment (n=6/group) by enzyme-linked immunosorbent assay colorimetric method. Data represent means±s.d. ***P<0.001 versus untreated control and ###P<0.001 versus EG, two-way analysis of variance followed by a post hoc analysis. C, untreated control (distilled water); EG, EG-treated group (0.8% EG/1% ammonium chloride (AC; NH4Cl) in drinking water); and EG+P4 and EG+P20, two PGG-treated groups (0.8% EG/1% AC+4 or 20 mg/kg of PGG in 2% methylcellulose). Kidney International 2011 79, 538-545DOI: (10.1038/ki.2010.458) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 3 Effect of 1,2,3,4,6-penta-O-galloyl-β-D-glucose (PGG) on antioxidant enzyme activity in ethylene glycol (EG)-treated rat kidneys. (a) Immunohistochemical staining for superoxide dismutase (SOD) expression in rat kidney tissues (n=6/group) obtained on days 7, 14, and 21 following EG treatment was performed and the average number of positive stained cells per high power field was counted from three independent experiments. Data represent means±s.d. ***P<0.001 versus untreated control; #P<0.05 and ###P<0.001 versus EG; and !!!P<0.001 versus EG+P4, two-way analysis of variance followed by a post hoc analysis. (b–c) Western blot analysis in EG-treated rat kidneys on day 21 following EG treatment for Cu/Zn SOD (b), catalase (c), glutathione peroxidase (c), and β-actin. Data of protein expression represent means±s.d. *P<0.05 versus untreated control and ##P<0.01 versus EG, one-way analysis of variance followed by a post hoc analysis. C, untreated control (distilled water); EG, EG-treated group (0.8% EG/1% ammonium chloride (AC; NH4Cl) in drinking water); and EG+P4 and EG+P20, two PGG-treated groups (0.8% EG/1% AC+4 or 20 mg/kg of PGG in 2% methylcellulose). Kidney International 2011 79, 538-545DOI: (10.1038/ki.2010.458) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 4 Effect of 1,2,3,4,6-penta-O-galloyl-β-D-glucose (PGG) on osteopontin (OPN) expression in ethylene glycol (EG)-treated rat kidneys. (a) Immunohistochemical staining for OPN in rat kidney tissues (n=6/group) obtained on day 21 following EG treatment was performed and the average number of stained cells per high power field was counted from three independent experiments. Data represent means±s.d. (b) Western blot analysis in EG-treated rat kidneys for OPN and β-actin. ***P<0.001 versus untreated control; ###P<0.001 versus EG; and !!!P<0.001 versus EG+P4, one-way analysis of variance followed by a post hoc analysis. C, untreated control (distilled water); EG, EG-treated group (0.8% EG/1% ammonium chloride (AC; NH4Cl) in drinking water); and EG+P4 and EG+P20, two PGG-treated groups (0.8% EG/1% AC+4 or 20 mg/kg of PGG in 2% methylcellulose). Kidney International 2011 79, 538-545DOI: (10.1038/ki.2010.458) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 5 Effect of PGG on cell death index TUNEL staining in EG treated rat kidneys. Cell death was assessed by TUNEL assay in rat kidney tissues (n=6/group) obtained on day 21 following EG treatment. Graph represents the average number of TUNEL positive stained cells per high power field. Data represent means±s.d. ###P<0.001 versus untreated control, and *P<0.05 and ***P<0.001 versus untreated control, ###P<0.001 versus EG, two-way analysis of variance followed by a post hoc analysis. C, untreated control (distilled water); EG, EG treated group (0.8% EG/1% AC (NH4Cl) in drinking water) and, EG+P4 and EG+P20; two PGG-treated groups (0.8% EG/1% AC+4 or 20 mg/kg of PGG in 2% methylcellulose). Kidney International 2011 79, 538-545DOI: (10.1038/ki.2010.458) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 6 Effect of 1,2,3,4,6-penta-O-galloyl-β-D-glucose (PGG) on hyaluronan expression in ethylene glycol (EG)-treated rat kidneys. (a) Immunohistochemical staining for renal hyaluronan expression in EG-treated rat kidneys (n=6/group) obtained on days 7, 14, and 21 following EG treatment. (b) The average number of hyaluronan-positive stained cells per high power field. Data represent means±s.d. *P<0.05 and ***P<0.001 versus untreated control; ###P<0.001 versus EG; and !P<0.05 versus EG+P4, two-way analysis of variance followed by a post hoc analysis. C, untreated control (distilled water); EG, EG-treated group (0.8% EG/1% ammonium chloride (AC; NH4Cl) in drinking water); and EG+P4 and EG+P20, two PGG-treated groups (0.8% EG/1% AC+4 or 20 mg/kg of PGG in 2% methylcellulose). Kidney International 2011 79, 538-545DOI: (10.1038/ki.2010.458) Copyright © 2011 International Society of Nephrology Terms and Conditions